| Literature DB >> 28856834 |
Keith C Ferdinand1, Kapil Yadav1, Samar A Nasser2, Helene D Clayton-Jeter3, John Lewin4, Dennis R Cryer5, Fortunato Fred Senatore6.
Abstract
Blacks are two to three times as likely as whites to die of preventable heart disease and stroke. Declines in mortality from heart disease have not eliminated racial disparities. Control and effective treatment of hypertension, a leading cause of cardiovascular disease, among blacks is less than in whites and remains a challenge. One of the driving forces behind this racial/ethnic disparity is medication nonadherence whose cause is embedded in social determinants. Eight practical approaches to addressing medication adherence with the potential to attenuate disparities were identified and include: (1) patient engagement strategies, (2) consumer-directed health care, (3) patient portals, (4) smart apps and text messages, (5) digital pillboxes, (6) pharmacist-led engagement, (7) cardiac rehabilitation, and (8) cognitive-based behavior. However, while data suggest that these strategies may improve medication adherence, the effect on ameliorating racial/ethnic disparities is not certain. This review describes the relationship between disparities and medication adherence, which likely plays a role in persistent disparities in cardiovascular morbidity and mortality. ©2017 Wiley Periodicals, Inc.Entities:
Keywords: Adherence; Food and Drug Administration; blacks; cardiovascular disease; health disparities; hypertension; race/ethnicity
Mesh:
Substances:
Year: 2017 PMID: 28856834 PMCID: PMC5638710 DOI: 10.1111/jch.13089
Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN: 1524-6175 Impact factor: 3.738